What a standardised site assessment tool actually measures
Choosing which sites will run a study is one of the earliest, highest-stakes decisions in a trial's operational planning, and it's often made on a mix of prior relationships, informal reputation, and a feasibility questionnaire that varies in rigour from sponsor to sponsor. Work developing a standardised, automated site assessment survey instrument makes the case for treating this decision with the same structured rigour applied to other parts of trial design.
Why informal site selection is a genuine risk, not just an inefficiency
A site chosen primarily on relationship history can turn out to lack the specific patient population, staff capacity, or infrastructure a particular protocol actually needs, discovered only after the study is already underway and a slow-enrolling or high-deviation site is dragging on overall timelines. The cost of a poor site selection decision doesn't show up at selection time; it shows up months later as enrolment shortfalls, protocol deviations, or data quality issues that trace back to a site that was never genuinely well matched to the study.
What a standardised instrument actually assesses
A structured, validated site assessment tool moves beyond a general feasibility questionnaire to systematically cover the specific factors that predict whether a site will actually deliver:
- Realistic patient population estimates, checked against the site's actual historical enrolment in comparable studies rather than an optimistic projection.
- Staff capacity and experience relevant to the specific protocol, not just general research experience, since a site experienced in one therapeutic area may be poorly positioned for a protocol with very different operational demands.
- Infrastructure specific to the study's requirements, appropriate storage, equipment, and digital systems, verified rather than assumed from a site's general reputation.
- Historical performance data, query resolution times, protocol deviation rates, and monitoring findings from previous studies, where available, as a genuinely predictive signal rather than relying on how the relationship with a sponsor has felt informally.
Why automation and standardisation specifically help here
A standardised, automated instrument doesn't replace human judgement in site selection, but it does two things an informal process struggles to do consistently: it applies the same criteria to every candidate site, removing the inconsistency that comes from different people evaluating different sites with different informal standards, and it creates a documented, comparable record that can be reviewed and improved over time as a sponsor learns which factors actually predicted successful site performance in past studies.
What this means for building or choosing a site selection process
- Use a structured instrument consistently across every candidate site for a given study, rather than applying more or less scrutiny depending on the strength of an existing relationship.
- Weight historical performance data where it's available, rather than treating every candidate site as a blank slate regardless of track record.
- Match assessment criteria to the specific protocol's actual demands, rather than a generic feasibility checklist that doesn't distinguish between very different kinds of studies.
- Build a feedback loop, tracking which assessment factors actually predicted good or poor site performance after the fact, so the assessment process itself improves over successive studies.
The broader point
Site selection sits at the intersection of relationship management and genuine operational risk assessment, and it's tempting to let the former dominate because it's more comfortable and more familiar. A standardised assessment instrument doesn't remove relationships from the equation, sites still need engagement and support to perform well, but it ensures the initial selection decision is grounded in the same kind of structured evidence a well-run study applies to everything else about its design.